Reata Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RETA Reata Pharmaceuticals Inc
CLX Clorox Co
COP ConocoPhillips
FBP First Bancorp
PTCT PTC Therapeutics Inc
ROKU Roku Inc
WORK Slack Technologies Inc
ARKW ARK Next Generation Internet ETF
SPOT Spotify Technology SA
GBTC Grayscale Bitcoin Trust (BTC)
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. The Company's lead product candidates include bardoxolone methyl, which is being studied in Phase III trial for the treatment of pulmonary arterial hypertension (PAH), associated with connective tissue disease (CTD-PAH), as well as a Phase II trial for the treatment of pulmonary hypertension due to interstitial lung disease (PH-ILD), and PAH, each of which are subsets of pulmonary hypertension (PH), Omaveloxolone, which is in Phase II clinical development for the treatment of multiple diseases, including Friedreich's ataxia, mitochondrial myopathies and metastatic melanoma.

Closing Price
$111.93
Day's Change
-8.07 (-6.72%)
Bid
--
Ask
--
B/A Size
--
Day's High
121.72
Day's Low
111.80
Volume
(Heavy Day)
Volume:
399,079

10-day average volume:
270,032
399,079

Display:

Providers:

UpdateCancel
6 providers
December 14, 2020
Portnoy Law: Lawsuit Filed On Behalf of Reata Pharmaceuticals, Inc. Investors

Click here to join the case The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Reata Pharmaceuticals, Inc. ("Reata" or "the Company") (NASDAQ: RETA) investors that acquired securities between October 15...(Globe Newswire)

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of Texas on behalf of investors that...(Globe Newswire)

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - December 14, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Reata Pharmaceuticals, Inc. (NASDAQ: RETA) ("Reata" or "the...(Newsfile)

RETA Final Deadline Notice: Rosen, Top Ranked Investor Counsel, Reminds Reata Pharmaceuticals, Inc. Investors of Important Deadline Today in Securities Class Action - RETA

New York, New York--(Newsfile Corp. - December 14, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, 2020, inclusive...(Newsfile)

Portnoy Law: Lawsuit Filed On Behalf of Reata Pharmaceuticals, Inc. Investors

Click here to join the case The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Reata Pharmaceuticals, Inc. ("Reata" or "the Company") (NASDAQ: RETA) investors that acquired securities between October 15...(Globe Newswire)

December 12, 2020
RETA FINAL DEADLINE ALERT: ROSEN, TRUSTED AND LEADING INVESTOR COUNSEL, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action - RETA

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, 2020, inclusive (the "Class Period"), of the important December 14, 2020...(PR Newswire)

December 11, 2020
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of Texas on behalf of investors that...(Globe Newswire)

IMMINENT DEADLINE Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc. - RETA

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, 2020, inclusive (the "Class Period"). (Globe Newswire)

DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - December 11, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Reata Pharmaceuticals, Inc. (NASDAQ: RETA) ("Reata" or "the...(Newsfile)

December 10, 2020
RETA FINAL DEADLINE: Top Ranked Rosen Law Firm Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action - RETA

New York, New York--(Newsfile Corp. - December 10, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, 2020, inclusive...(Newsfile)

MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - December 10, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Reata Pharmaceuticals, Inc. ("Reata" or "the Company")...(Newsfile)

December 09, 2020
FINAL DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action - RETA

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, 2020, inclusive (the "Class Period"), of the important December 14, 2020...(Globe Newswire)

DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reata Pharmaceuticals, Inc. ("Reata" or "the Company") (NASDAQ: RETA) for violations of the securities laws. (BusinessWire)

DEADLINE FOR RETA INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.

New York, New York--(Newsfile Corp. - December 9, 2020) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the lead plaintiff deadline in a securities class action that has been filed on behalf of investors...(Newsfile)

RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you...(Globe Newswire)

MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - December 9, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Reata Pharmaceuticals, Inc. (NASDAQ: RETA) ("Reata" or "the...(Newsfile)

December 08, 2020
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Eastern District of Texas on behalf of investors that...(BusinessWire)

DEC. 14 DEADINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc.- RETA

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from October 15, 2019 through August 7, 2020, inclusive (the "Class Period"). The...(Globe Newswire)

MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - December 8, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Reata Pharmaceuticals, Inc. (NASDAQ: RETA) ("Reata" or "the...(Newsfile)

December 07, 2020
Rosen, A Top Ranked Law Firm, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - RETA

New York, New York--(Newsfile Corp. - December 7, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between October 15, 2019 and August 7, 2020, inclusive...(Newsfile)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.